|
Re: European Atherosclerosis Society Congress May 29 - June 1
|
4
|
Resverlogix Corp.
|
May 27, 2016 05:00PM
|
|
Re: Wikipedia on Investor Relations: Goal is Fair Valuation
|
2
|
Zenith Epigenetics
|
May 28, 2016 11:08AM
|
|
Re: it's probably about time they
|
2
|
Resverlogix Corp.
|
May 31, 2016 12:24PM
|
|
Re: Zenith has been quiet.......too quiest
|
3
|
Zenith Epigenetics
|
Jun 06, 2016 06:29PM
|
|
Re: At 1.33 we're over both the 20 and 50 DMAs....
|
3
|
Resverlogix Corp.
|
Jun 09, 2016 10:11AM
|
|
Re: Hide the Ball
|
2
|
Resverlogix Corp.
|
Jun 09, 2016 12:00PM
|
|
Re: Litter box is full !!!
|
3
|
Zenith Epigenetics
|
Jun 09, 2016 01:15PM
|
|
Re: Zenith has been quiet.......too quiest
|
3
|
Zenith Epigenetics
|
Jun 09, 2016 01:32PM
|
|
Re: More sites now recruiting for ZEN003694 NCT02705469 trial
|
1
|
Zenith Epigenetics
|
Jun 09, 2016 06:46PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 04:47PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
2
|
Resverlogix Corp.
|
Jun 13, 2016 05:16PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 07:00PM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 09:16AM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 11:31AM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
2
|
Zenith Epigenetics
|
Jun 16, 2016 08:35AM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
3
|
Zenith Epigenetics
|
Jun 16, 2016 10:21AM
|
|
Share Incentives
|
1
|
Zenith Epigenetics
|
Jun 20, 2016 12:26PM
|
|
Re: Compounds and Autoimmune
|
3
|
Resverlogix Corp.
|
Jun 21, 2016 05:23PM
|
|
Re: Dr Sweeney
|
4
|
Resverlogix Corp.
|
Jun 22, 2016 11:09AM
|
|
Re: Dr Sweeney
|
2
|
Resverlogix Corp.
|
Jun 22, 2016 11:34AM
|
